Related Experiment Video
Updated: Apr 4, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Controversies in the Pharmacological Treatment of Uveitis
Robert J Barry, Alastair K Denniston1
1Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation trust, Mindelsohn Way, Edgbaston, Birmingham, B15 2WB, UK. a.denniston@bham.ac.uk.
Abstract:
Uveitis is a term applied to a broad range of conditions characterized by intraocular inflammation. The pharmacological treatment of uveitis is controversial, with limited high-level evidence to inform most of the key treatment decisions that face the patient and clinician on a daily basis. In this review we identified twelve systematic reviews (including two Cochrane reviews) focused on key therapeutic questions in infectious and noninfectious uveitis. Our analysis of these reviews demonstrates the paucity of trial evidence available to inform these important clinical decisions. We consider the reasons for this, and look at the way forward for clinical trials in uveitis, so that we can move from controversy to clarity in the pharmacotherapy of uveitis.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

